SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-139440
Filing Date
2024-05-15
Accepted
2024-05-15 16:43:55
Documents
15
Period of Report
2024-05-15
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d824247d8k.htm   iXBRL 8-K 25058
2 EX-99.1 d824247dex991.htm EX-99.1 9018
6 GRAPHIC g824247g0515033240957.jpg GRAPHIC 3709
  Complete submission text file 0001193125-24-139440.txt   165260

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA lnth-20240515.xsd EX-101.SCH 2853
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE lnth-20240515_lab.xml EX-101.LAB 17994
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE lnth-20240515_pre.xml EX-101.PRE 11263
18 EXTRACTED XBRL INSTANCE DOCUMENT d824247d8k_htm.xml XML 3641
Mailing Address 331 TREBLE COVE ROAD NORTH BILLERICA MA 01862
Business Address 331 TREBLE COVE ROAD NORTH BILLERICA MA 01862 978 671-8001
Lantheus Holdings, Inc. (Filer) CIK: 0001521036 (see all company filings)

IRS No.: 352318913 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36569 | Film No.: 24952036
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)